oral glp 1 agonist for type 2 diabetes A Review on Semaglutide: An Glucagon-Like Peptide Receptor in Management of Mellitus | Diabetes Therapy NEW: This new oral GLP-1
Description
A key differential side effect for Retatrutide is a transient, dose-dependent increase in heart rate observed in the clinical trials, which necessitates careful cardiac screening and monitoring by a supervising physician
Combination approaches are also gaining traction in clinical development as a potential means to improve efficacy and address risk factors / comorbidities
doi:10.1042/BST20160474
After the introductory period, ongoing fills run $299$349 per month
